Logo

Rosetta Licenses Resolver to Abbott Labs

Mar 25, 2002

NEW YORK, March 25 - Rosetta Biosoftware on Monday said it has licensed its Resolver gene-expression data-analysis system to Abbott Laboratories.

 

Financial terms of the deal were not disclosed, though Agilent Technologies, as usual, will distribute the bioinformatics tool.

 

The agreement is the second one in as many weeks for Rosetta, which licensed the Resolver system to Genencor on March 11.

Breaking News
The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.